BIO 2024Products & Services Re-purposed anti-inflammatory small molecule
Re-purposed anti-inflammatory small molecule
Exhibitor
Bicoll GmbH
New non-steroid with cortisol effect: maintained anti-inflammatory efficacy with improved safety profile.
1. Bicoll has tested and identified drug AP26784 with strong anti-inflammatory profile.
2. AP26784 is a generic compound with a known profile for different dermatologic indications.
3. New IP created (2023).
4. AP26784 has an opportunity to be re-purposed and move to other immune-induced inflammatory diseases.
1. Bicoll has tested and identified drug AP26784 with strong anti-inflammatory profile.
2. AP26784 is a generic compound with a known profile for different dermatologic indications.
3. New IP created (2023).
4. AP26784 has an opportunity to be re-purposed and move to other immune-induced inflammatory diseases.
Open to partnerships and out-licensing